144 results
8-K
EX-99.1
ENVB
Enveric Biosciences Inc
26 Mar 24
Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2023
8:00am
, increasing the attractiveness of these molecules for further development. Already in 2024, we have seen returns on this strategy in the form of out
8-K
EX-99.1
ENVB
Enveric Biosciences Inc
20 Oct 23
Enveric Biosciences to Present at the Centurion One 5th Global Summit
8:05am
with registered investors, showcasing Enveric’s business and clinical development strategy, recent corporate achievements, and anticipated milestones
8-K
EX-99.1
ehpmpar
11 Oct 23
Enveric Biosciences Announces Two Poster Presentations at the 6th Neuropsychiatric Drug Development Summit
8:05am
8-K
EX-99.1
2f03twy
24 May 23
Regulation FD Disclosure
8:00am
8-K
EX-99.1
4ua7np9 kfs1al5c
18 May 23
Enveric Biosciences Receives Notice of Allowance from USPTO for Novel Prodrug of Psilocin
8:00am
8-K
EX-99.1
t5fget
10 Apr 23
Enveric Biosciences to Participate in Benzinga Psychedelics Capital Conference
10:11am
8-K
7go 8mt6kcsdzfu
13 Sep 22
Departure of Directors or Certain Officers
2:44pm
424B3
wxwt3
28 Jul 22
Prospectus supplement
4:32pm
8-K
EX-99.1
uky4vfdk
19 Jul 22
Enveric Biosciences Announces Formation of Scientific Advisory Board to Drive Further Growth of Next-Generation Mental Health Medicines
8:25am
8-K
EX-99.1
lvo0yt2cyv rxhtt
1 Apr 22
Enveric Biosciences Reports Full-Year 2021 Financial Results and Provides Business Update
1:34pm
8-K
EX-99.1
dbhhdnf5
19 Jan 22
Regulation FD Disclosure
3:14pm
8-K
8byfon5
18 Nov 21
Departure of Directors or Certain Officers
4:05pm
425
jjgd5g ld14p
3 Sep 21
Business combination disclosure
5:26pm